Clinical Trial Results:
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Seven Arm, Four-Period Cross-over, Incomplete Block Design, 7-Day Dosing Study to Assess the Dose-Response, Safety, and Efficacy of EP-101 in Subjects with Moderate to Severe COPD
Summary
|
|
EudraCT number |
2011-001810-32 |
Trial protocol |
GB |
Global completion date |
19 Dec 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
08 Jun 2018
|
First version publication date |
14 Jul 2017
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
EP-101-03 updated results EP-101-03 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.